Nevro Corp - Company Profile
Powered by 
All the data and insights you need on Nevro Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Nevro Corp Strategy Report
- Understand Nevro Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Nevro Corp (Nevro) provides novel solutions to improve the life of people suffering from chronic pain in trunks and limbs. The company has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. It delivers Nevro's proprietary 10 kHz Therapy to the patients.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s R&D objective is to continue to enhance patient outcomes and further expand patient access to 10 kHz Therapy by making enhancements to Senza and development of new indications. Nevro is developing 10 kHz Therapy for treating various chronic pains including, painful diabetic neuropathy and non-surgical refractory back pain. As of December 31, 2022, it owned 277 issued patents globally including 163 issued US utility patents, two US design patents, five Australian design patents, 55 issued Australian utility patents, 20 European utility patents, seven European design patents, four Japanese patents, two Korean utility patents, one issued Korean design patent, four issued Chinese utility patents, three issued Chinese design patents, two Canadian utility patents and seven United Kingdom design patent and two Canadian utility patents. The company also held 120 patent applications including 52 pending patent applications in the US and 68 PCT patent applications across Europe, Australia, Canada, Japan, China, Costa Rica, India and Korea. In FY2022, the company spent US$53.1 million on its R&D activities, which grew 11.3%, amounting to 13.06% of the company’s annual revenue.
Geographical Segments
Target Markets
Switzerland, the UK, Germany, Austria, Belgium, Luxembourg, the Netherlands, Norway, Sweden and Australia.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer